natgillin/translations-raw huggingface dataset:
20 Zinkchlorid Glycerol Metacresol Phenol Dinatriumphosphatdihydrat Natriumhydroxid (til pH- justering) Saltsyre (til pH- justering) Protaminsulphat Vand til injektionsvæsker
Zinc chloride Glycerol Metacresol Phenol Disodium phosphate dihydrate Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Protamine sulphate Water for injections
6 uger bruges eller medbringes som reserve (under 30°C).
6 weeks when used or carried as a spare (below 30°C).
Cylinderampullerne må kun anvendes sammen med produkter, som er kompatible hermed, og som tillader effektiv og sikker funktion af cylinderampullen.
21 Cartridges should only be used in combination with products that are compatible with them and allow the cartridge to function safely and effectively.
Efter, at Insulatard Penfill er taget ud af køleskabet, bør Penfill opnå stuetemperatur (ikke over 25°C) inden insulinet opblandes, som beskrevet første gang.
After removing Insulatard Penfill from the refrigerator it is recommended to allow the Penfill to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
21 Novo Nordisk A/ S Novo Allé DK- 2880 Bagsværd Danmark
Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd Denmark
Insulatard NovoLet 100 IE/ ml injektionsvæske, suspension i en fyldt pen
Insulatard NovoLet 100 IU/ ml suspension for injection in a pre-filled pen.
4. 4).
23 Dosage adjustment may be necessary when transferring patients from one insulin preparation to another (see section 4.4).
Insulatard NovoLet er beregnet til anvendelse sammen med NovoFine nåle.
Insulatard NovoLet is designed to be used with NovoFine needles.
NovoLet dispenserer 2- 78 enheder i spring på to enheder.
NovoLet delivers 2-78 units in increments of 2 unitsThe pens should be primed before injection so that the dose selector returns to zero and a drop of insulin appears at the needle top.
Pennene skal klargøres før injektion, således at dosisvælgeren nulstilles, og der kommer en dråbe insulin til syne på nålens spids.
The dose is set by turning the selector, which returns to zero during the injection.
Dosis vælges ved at dreje dosisvælgeren, som nulstilles under injektionen.
Insulatard is accompanied by a package leaflet with detailed instruction for use to be followed.
Nogle få patienter, som har oplevet hypoglykæmiske reaktioner efter skift fra animalsk insulin, har
A few patients who have experienced hypoglycaemic reactions after transfer from animal source insulin have reported that early warning symptoms of hypoglycaemia were less pronounced or different from those experienced with their previous insulin.
Patientens evne til at koncentrere sig og reagere kan være svækket på grund af hypoglykæmi.
25 The patient’ s ability to concentrate and react may be impaired as a result of hypoglycaemia.
25 Hypoglykæmi er, som ved andre insulintyper, den oftest forekommende bivirkning.
As for other insulin products, in general, hypoglycaemia is the most frequently occurring undesirable effect.
Ikke almindelig - Diabetisk retinopati Blodglucosekontrol forbedret gennem lang tid nedsætter risikoen for forværring af diabetisk retinopati.
Uncommon - Diabetic retinopathy Long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.
Immunsystemet Ikke almindelig - Nældefeber, udslæt Meget sjælden - Anafylaktiske reaktioner Symptomer på almen hypersensibilitet kan indbefatte hududslæt, kløe, svedtendens, gastrointestinalt ubehag, angioneurotisk ødem, åndedrætsbesvær, hjertebanken, blodtryksfald og besvimelse/ tab af bevidsthed.
26 Symptoms of generalised hypersensitivity may include generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation, reduction in blood pressure and fainting/ loss of consciousness.
26 • Svær hypoglykæmi, hvor patienten er blevet bevidstløs, kan behandles med glucagon (0, 5 - 1 mg) indgivet intramuskulært eller subkutant af en instrueret person eller med glucose indgivet intravenøst af en medicinsk uddannet person.
It is therefore recommended that the diabetic patients carry some sugar lumps, sweets, biscuits or sugary fruit juice. • Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
Metabolisme Human insulin nedbrydes af insulinprotease eller insulinnedbrydende enzymer og muligvis af disulfidisomeraseproteinet.
27 Human insulin is reported to be degraded by insulin protease or insulin-degrading enzymes and possibly protein disulfide isomerase.
27 6. 1 Hjælpestoffer
6.1 List of excipients
6 uger hvis det bruges eller medbringes som reserve (under 30°C).
6 weeks when used or carried as a spare (below 30°C).
Cylinderampullen er af glas (type 1), indeholder et gummistempel af brombutyl og er lukket med en gummiskive af brombutyl/ polyisopren.
28 bromobutyl/ polyisoprene rubber stopper.
5 og 10 fyldte penne x 3 ml Ikke alle pakningsstørrelser er nødvendigvis markedsført.
Not all pack sizes may be marketed.
Insulatard NovoLet må kun anvendes af én person.
Insulatard NovoLet is for single person use only.
Efter, at Insulatard NovoLet er taget ud af køleskabet, bør NovoLet opnå stuetemperatur (ikke over 25°C) inden insulinet opblandes, som beskrevet første gang.
After removing Insulatard NovoLet from the refrigerator it is recommended to allow the NovoLet to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
28 Ikke anvendte lægemidler samt affald heraf bør destrueres i henhold til lokale retningslinier.
Any unused product or waste material should be disposed of in accordance with local requirements.
EU/ 1/ 02/ 233/ 008, 009
EU/ 1/ 02/ 233/ 008-009
Insulatard InnoLet 100 IE/ ml injektionsvæske, suspension i en fyldt pen
Insulatard InnoLet 100 IU/ ml suspension for injection in a pre-filled pen.
4. 4).
30 Dosage adjustment may be necessary when transferring patients from one insulin preparation to another (see section 4.4).
Insulatard Innolet er beregnet til anvendelse sammen med korte NovoFine nåle på 8 mm eller derunder.
Insulatard InnoLet is designed to be used with NovoFine short cap needles of 8 mm or shorter in length.
Som ved al anden insulinbehandling, kan der opstå reaktioner på injektionsstedet og medføre smerte, kløe, udslæt, hævelse og inflammation.
31 As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
31 Nogle få patienter, som har oplevet hypoglykæmiske reaktioner efter skift fra animalsk insulin, har rapporteret, at de tidlige advarselssymptomer på hypoglykæmi var mindre udtalte eller forskellige fra dem, som de havde oplevet med deres tidligere insulin.
A few patients who have experienced hypoglycaemic reactions after transfer from animal source insulin have reported that early warning symptoms of hypoglycaemia were less pronounced or different from those experienced with their previous insulin.
Patientens evne til at koncentrere sig og reagere kan være svækket på grund af hypoglykæmi.
32 The patient’ s ability to concentrate and react may be impaired as a result of hypoglycaemia.
32 Hypoglykæmi er, som ved andre insulintyper, den oftest forekommende bivirkning.
As for other insulin products, in general, hypoglycaemia is the most frequently occurring undesirable effect.
Immunsystemet Ikke almindelig - Nældefeber, udslæt Meget sjælden - Anafylaktiske reaktioner Symptomer på almen hypersensibilitet kan indbefatte hududslæt, kløe, svedtendens, gastrointestinalt ubehag, angioneurotisk ødem, åndedrætsbesvær, hjertebanken, blodtryksfald og besvimelse/ tab af bevidsthed.
33 Symptoms of generalised hypersensitivity may include generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation, reduction in blood pressure and fainting/ loss of consciousness.
33 4. 9 Overdosering
4.9 Overdose
Det anbefales derfor, at diabetespatienterne bærer nogle sukkerknalder, slik, småkager eller sukkerholdig frugtjuice på sig. • Svær hypoglykæmi, hvor patienten er blevet bevidstløs, kan behandles med glucagon (0, 5 - 1 mg) indgivet intramuskulært eller subkutant af en instrueret person eller med glucose indgivet intravenøst af en medicinsk uddannet person.
It is therefore recommended that the diabetic patients carry some sugar lumps, sweets, biscuits or sugary fruit juice. • Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
Glucose skal også gives intravenøst, hvis patienten ikke responderer på glucagon inden for 10 - 15 minutter.
Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
Insuliner og analoger til injektion, middellang virkningstid, insulin (human). ATC- kode:
ATC code:
Metabolisme Human insulin nedbrydes af insulinprotease eller insulinnedbrydende enzymer og muligvis af disulfidisomeraseproteinet.
34 Human insulin is reported to be degraded by insulin protease or insulin-degrading enzymes and possibly protein disulfide isomerase.
34 De prækliniske data viser ingen særlig risiko for mennesker vurderet ud fra konventionelle undersøgelser af sikkerhedsfarmakologi, toksicitet efter gentagne doser, genotoksicitet, karcinogenicitet, og reproduktionstoksicitet.
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.
Cylinderampullen er af glas (type 1), indeholder et gummistempel af brombutyl og er lukket med en gummiskive af brombutyl/ polyisopren.
35 bromobutyl/ polyisoprene rubber stopper.
Insulatard InnoLet må kun anvendes af én person.
Insulatard InnoLet is for single person use only.
35 Insulinpræparater, som har været frosne, må ikke anvendes.
Insulin preparations which have been frozen must not be used.
Efter, at Insulatard InnoLet er taget ud af køleskabet, bør InnoLet opnå stuetemperatur (ikke over 25°C) inden insulinet opblandes, som beskrevet første gang.
After removing Insulatard InnoLet from the refrigerator it is recommended to allow the InnoLet to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
Insulatard FlexPen 100 IE/ ml injektionsvæske, suspension i en fyldt pen
Insulatard FlexPen 100 IU/ ml suspension for injection in a pre-filled pen.
37 Indgivelsesmåde Til subkutan anvendelse.
37 Dosage adjustment may be necessary when transferring patients from one insulin preparation to another (see section 4.4).
Insulatard FlexPen er beregnet til anvendelse sammen med korte NovoFine nåle på 8 mm eller derunder.
Insulatard FlexPen is designed to be used with NovoFine short cap needles of 8 mm or shorter in length.
4. 8 og 4. 9)..
Hypoglycaemia may occur if the insulin dose is too high in relation to the insulin requirement (see sections 4.8 and 4.9).
Som ved al anden insulinbehandling, kan der opstå reaktioner på injektionsstedet og medføre smerte, kløe, udslæt, hævelse og inflammation.
38 As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation.
Patientens evne til at koncentrere sig og reagere kan være svækket på grund af hypoglykæmi.
39 The patient’ s ability to concentrate and react may be impaired as a result of hypoglycaemia.
39 Hypoglykæmi er, som ved andre insulintyper, den oftest forekommende bivirkning.
As for other insulin products, in general, hypoglycaemia is the most frequently occurring undesirable effect.
Ikke almindelige - Diabetisk retinopati Blodglucosekontrol forbedret gennem lang tid nedsætter risikoen for forværring af diabetiskretinopati.
Uncommon - Diabetic retinopathy Long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.
Immunsystemet Ikke almindelig - Nældefeber, udslæt Meget sjælden - Anafylaktiske reaktioner Symptomer på almen hypersensibilitet kan indbefatte hududslæt, kløe, svedtendens, gastrointestinalt ubehag, angioneurotisk ødem, åndedrætsbesvær, hjertebanken, blodtryksfald og besvimelse/ tab af bevidsthed.
40 Symptoms of generalised hypersensitivity may include generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation, reduction in blood pressure and fainting/ loss of consciousness.
40 • Svær hypoglykæmi, hvor patienten er blevet bevidstløs, kan behandles med glucagon (0, 5 - 1 mg) indgivet intramuskulært eller subkutant af en instrueret person eller med glucose indgivet intravenøst af en medicinsk uddannet person.
It is therefore recommended that the diabetic patients carry some sugar lumps, sweets, biscuits or sugary fruit juice. • Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
Metabolisme Human insulin nedbrydes af insulinprotease eller insulinnedbrydende enzymer og muligvis af disulfidisomeraseproteinet.
41 Human insulin is reported to be degraded by insulin protease or insulin-degrading enzymes and possibly protein disulfide isomerase.
41 6. 1 Hjælpestoffer
6.1 List of excipients
Cylinderampullen er af glas (type 1), indeholder et gummistempel af brombutyl og er lukket med en gummiskive af brombutyl/ polyisopren.
42 bromobutyl/ polyisoprene rubber stopper.
Insulatard FlexPen må kun anvendes af én person.
Insulatard FlexPen is for single person use only.
Efter, at Insulatard FlexPen er taget ud af køleskabet, bør FlexPen opnå stuetemperatur (ikke over 25°C) inden insulinet opblandes, som beskrevet første gang.
After removing Insulatard FlexPen from the refrigerator it is recommended to allow the FlexPen to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
42 Ikke anvendte lægemidler samt affald heraf bør destrueres i henhold til lokale retningslinier.
Any unused product or waste material should be disposed of in accordance with local requirements.
Dato for første markedsføringstilladelse.
Date of first authorisation:
Insulatard Penfill og FlexPen:
Insulatard Penfill and FlexPen
47 MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE OG PÅ DEN INDRE EMBALLAGE
47 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Insulatard 40 IE/ ml injektionsvæske, suspension i et hætteglas Insulin, human (rDNA)
Insulatard 40 IU/ ml suspension for injection in a vial Insulin human (rDNA)
1 ml suspension indeholder 40 IE (1, 4 mg) human insulin (rDNA).
1 ml suspension contains 40 IU (1.4 mg) of insulin human (rDNA).
ANVENDELSESMÅDE OG ADMINSTRATIONSVEJ( E)
METHOD AND ROUTE OF ADMINISTRATION
Må ikke opbevares i køleskab eller opbevares over 25°C
SPECIAL STORAGE CONDITIONS 48 Store in a refrigerator (2°C - 8°C) Do not freeze Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C
Insulatard hætteglas 40 IE/ ml
Insulatard vial 40 IU/ ml
Insulatard 40 IE/ ml injektionsvæske, suspension Insulin, human (rDNA) s. c.
Insulatard 40 IU/ ml suspension for injection Insulin human (rDNA) SC use
50 MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE OG PÅ DEN INDRE EMBALLAGE
50 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Insulatard 100 IE/ ml injektionsvæske, suspension i et hætteglas Insulin, human (rDNA)
Insulatard 100 IU/ ml suspension for injection in a vial Insulin human (rDNA)
1 ml suspension indeholder 100 IE (3, 5 mg) human insulin (rDNA).
1 ml suspension contains 100 IU (3.5 mg) of insulin human (rDNA).
Må ikke opbevares i køleskab eller opbevares over 25°C
SPECIAL STORAGE CONDITIONS 51 Store in a refrigerator (2°C - 8°C) Do not freeze Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C
Insulatard hætteglas 100 IE/ ml
Insulatard vial 100 IU/ ml
Insulatard 100 IE/ ml injektionsvæske, suspension Insulin, human (rDNA) s. c.
Insulatard 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
53 MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE OG PÅ DEN INDRE EMBALLAGE
53 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Injektionsvæske, suspension 1 x 10 ml Dette er del af en multipakning og ikke beregnet til salg enkeltvis
Suspension for injection 1 x 10 ml This is part of a multipack and not for sale of individual vials
Må ikke opbevares i køleskab eller opbevares over 25°C
SPECIAL STORAGE CONDITIONS 54 Store in a refrigerator (2°C - 8°C) Do not freeze Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C
55 MÆRKNING, DER SKAL ANFØRES PÅ PAKNINGEN
55 PARTICULARS TO APPEAR ON THE PACKAGING
YDRE INDPAKNINGSETIKET PÅ MULTIPAKNINGEN
OUTER WRAPPER LABELON MULTIPACKS
Insulatard 40 IE/ ml injektionsvæske, suspension i et hætteglas Insulin, human, rDNA
Insulatard 40 IU/ ml suspension for injection in a vial Insulin human (rDNA)
Injektionsvæske, suspension 5 x (1 x 10 ml) Dette er del af en multipakning og ikke beregnet til salg enkeltvis
Suspension for injection 5 x (1 x 10 ml) This is a multipack and not for sale of individual vials
Opbevares i køleskab (2°C- 8°C)
SPECIAL STORAGE CONDITIONS
Må ikke opbevares i køleskab eller opbevares over 25°C
56 Store in a refrigerator (2°C - 8°C) Do not freeze Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C
57 MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE OG PÅ DEN INDRE EMBALLAGE
57 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Må ikke opbevares i køleskab eller opbevares over 25°C
SPECIAL STORAGE CONDITIONS 58 Store in a refrigerator (2°C - 8°C) Do not freeze Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C
59 MÆRKNING, DER SKAL ANFØRES PÅ PAKNINGEN
59 PARTICULARS TO APPEAR ON THE PACKAGING
Må ikke opbevares i køleskab eller opbevares over 25°C
60 Store in a refrigerator (2°C - 8°C) Do not freeze Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C
61 MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE OG PÅ DEN INDRE EMBALLAGE
61 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Insulatard Penfill 100 IE/ ml injektionsvæske, suspension i cylinderampul Insulin, human (rDNA)
Insulatard Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)
Subkutan anvendelse Penfill cylinderampuller er beregnet til anvendelse sammen med Novo Nordisk insulindispenseringssystemer Opblandes som angivet i indlægssedlen Læs indlægssedlen inden brug Insulatard Penfill må kun anvendes af én person
Subcutaneous use Penfill cartridges for use with Novo Nordisk insulin devices Resuspend according to instructions Read the package leaflet before use Insulatard Penfill is for use by one person only
63 MINDSTEKRAV TIL MÆRKNING, DER SKAL ANFØRES PÅ SMÅ INDRE EMBALLAGER
63 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Insulatard Penfill 100 IE/ ml injektionsvæske, suspension Insulin, human (rDNA) s. c.
Insulatard Penfill 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
64 MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE OG PÅ DEN INDRE EMBALLAGE
64 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Insulatard NovoLet 100 IE/ ml injektionsvæske, suspension i en fyldt pen Insulin, human (rDNA)
Insulatard NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Subkutan anvendelse Insulatard NovoLet er beregnet til anvendelse sammen med NovoFine nåle Opblandes som angivet i indlægssedlen Læs indlægssedlen inden brug Insulatard NovoLet må kun anvendes af én person
Subcutaneous use Insulatard NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Insulatard NovoLet is for use by one person only
Opbevares i køleskab (2°C- 8°C) Må ikke nedfryses Lysfølsomt, bør opbevares mørkt Efter ibrugtagning:
Store in a refrigerator (2°C - 8°C) Do not freeze Protect from light During use: do not refrigerate or store above 30°C
66 MINDSTEKRAV TIL MÆRKNING, DER SKAL ANFØRES PÅ SMÅ INDRE EMBALLAGER
66 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Insulatard NovoLet 100 IE/ ml injektionsvæske, suspension Insulin, human (rDNA) s. c.
Insulatard NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
67 MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE OG PÅ DEN INDRE EMBALLAGE
67 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Insulatard InnoLet 100 IE/ ml injektionsvæske, suspension i en fyldt pen Insulin, human (rDNA)
Insulatard InnoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
Subkutan anvendelse Insulatard InnoLet er beregnet til anvendelse sammen med NovoFine S nåle Opblandes som angivet i indlægssedlen Læs indlægssedlen inden brug Insulatard InnoLet må kun anvendes af én person
Subcutaneous use Insulatard InnoLet is designed to be used with NovoFine S needles Resuspend according to instructions Read the package leaflet before use Insulatard InnoLet is for use by one person only
69 MINDSTEKRAV TIL MÆRKNING, DER SKAL ANFØRES PÅ SMÅ INDRE EMBALLAGER
69 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Insulatard InnoLet 100 IE/ ml injektionsvæske, suspension Insulin, human (rDNA) s. c.
Insulatard InnoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
70 MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE OG PÅ DEN INDRE EMBALLAGE
70 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
Insulatard FlexPen 100 IE/ ml injektionsvæske, suspension i en fyldt pen Insulin, human (rDNA)
Insulatard FlexPen 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)
injektionsvæske, suspension 1 x 3 ml 5 x 3 ml 10 x 3 ml
Suspension for injection 1 x 3 ml 5 x 3 ml 10 x 3 ml
Beregnet til brug sammen med NovoFine eller NovoTwist engangsnåle med en længde på op til 8 mm Nålene forhandles separat Opblandes som angivet i indlægssedlen Læs indlægssedlen inden brug Insulatard FlexPen må kun anvendes af én person
Designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm Needles are not included Resuspend according to instructions Read the package leaflet before use Insulatard FlexPen is for use by one person only
Bruges inden 6 uger
71 EXP/ During use: use within 6 weeks
Insulatard FlexPen 100 IE/ ml injektionsvæske, suspension Insulin, human (rDNA) s. c.
Insulatard FlexPen 100 IU/ ml suspension for injection Insulin human (rDNA) SC use
74 INDLÆGSSEDDEL:
74 PACKAGE LEAFLET:
De kan få brug for at læse den igen. – Spørg lægen, diabetessygeplejersken eller på apoteket, hvis der er mere, De vil vide. – Lægen har ordineret Insulatard til Dem personligt.
You may need to read it again. – If you have any further questions, ask your doctor, diabetes nurse or your pharmacist. – This medicine has been prescribed for you.
VIRKNING AF INSULATARD, OG HVAD DE SKAL BRUGE DET TIL
WHAT INSULATARD IS AND WHAT IT IS USED FOR
Insulatard er human insulin til diabetesbehandling.
Insulatard is human insulin to treat diabetes.
24 timer.
This means that it will start to lower your blood sugar about 1½ hours after you take it, and the effect will last for approximately 24 hours.
Insulatard gives ofte i kombination med hurtigtvirkende insulinprodukter.
Insulatard is often given in combination with fast-acting insulin products.
DET SKAL DE VIDE, FØR DE BEGYNDER AT BRUGE INSULATARD
BEFORE YOU USE INSULATARD
Brug ikke Insulatard
Do not use Insulatard
Vær ekstra forsigtig med at bruge Insulatard
Take special care with Insulatard